GLP-1 drugs linked to reduced dementia risk: study (NYSE:NVO)
2024-06-22
Devonyu A new peer-reviewed study suggested this week that GLP-1 drugs, popularly used for weight loss, are associated with a lower risk of dementia in older people with diabetes. The trial considered real-world data from Sweden using more than 88,000 patients aged 65 or older with type 2 diabetes mellitusContinue Reading